Cell Signalling

BIOGRAPHY

ACADEMIC POSITION:
Kenan Distinguished Professor, Department of Pharmacology

EDUCATION:
• University of California, Los Angeles BS 1975 Biology
• University of California, Irvine PhD 1981 Microbiology
• Harvard Medical School & Dana-Farber Cancer Postdoc 1981-1985 Pathology

PROFESSIONAL POSITIONS:
1985-1992 Staff Scientist, La Jolla Cancer Research Foundation, La Jolla, CA
1992-1995 Associate Professor, Department of Pharmacology, Curriculum in Genetics, and Member, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
1992-1996 Member, NIH Pathology B Study Section
1991-1992 Consultant, Dupont Merck Pharmaceuticals
1994 Consultant, Eisai Research Institute
1993-1995 Consultant, Bristol-Myers Squibb
1994 Consultant, Pfizer
1995-present Professor, Department of Pharmacology, University of North Carolina, Chapel Hill, NC
1996–1997 Consultant, Biomeasure
1996-2000 Editorial Board, Journal of Biological Chemistry
1997-1998 Consultant, Dupont-Merck
1998 Consultant, Schering-Plogh
1998-present Editorial Board, Molecular and Cellular Biology
1998-2004 Board of Advisors, National Neurofibromatosis Foundation
1998-present Director, NIH Cancer Cell Biology Training Grant
1999-present Susan G Komen Breast Cancer Review Panel
2000 Consultant, Tularik
1999-2002 Associate Editor, Cancer Research
2000-present Editorial Board, Cancer Letters
2001-present Member, Faculty of 1000
2002 Consultant, PPD Discovery
2003-present Consultant, Upstate Biotechnology
2003-present Consultant, Chemicon
2003-present Editorial Board, Cancer Therapy
2004-present Editorial Board, Molecular Cancer Therapeutics

AWARDS AND HONORS:
1990-1995 American Cancer Society Faculty Research Award
1985-1986 NIH NRSA Postdoctoral Fellowship
1983-1985 Damon Runyon-Walter Winchell Postdoctoral Fellowship

RESEARCH INTERESTS:
Ras superfamily GTPases, oncogenes, signal transduction, and target-based anti-cancer drug discovery.